Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DYH42L
|
|||
| Drug Name |
INXN 4001
|
|||
| Drug Type |
Gene therapy
|
|||
| Indication | Heart failure [ICD-11: BD10-BD13] | Phase 1 | [1] | |
| Company |
Intrexon
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03409627) Novel INXN-4001 Triple Effector Plasmid in Heart Failure. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.